Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |
mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.7 |
mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.025 | 0.7 |